Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Elderly-onset neuromyelitis optica spectrum disorders.
Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Changes of Synaptic Plasticity in Multiple Sclerosis.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
A sphenoid sinus mucocele simulating as retro bulbar optic neuritis.
[Teriflunomide for treatment of multiple sclerosis.]
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195.
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
[Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.
Development and implementation of microsimulation models of neurological conditions.
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Glial influences on BBB functions and molecular players in immune cell trafficking.
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration.

Pages